--- title: "This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/285240940.md" description: "Top Wall Street analysts have initiated coverage on several companies with varying ratings. Seaport Global's Jay Goldberg rated Applied Materials (AMAT) as Buy with a $500 target. Citizens' Jonathan Wolleben rated Biomea Fusion (BMEA) as Market Outperform with a $9 target. Guggenheim's Seamus Fernandez rated Aclaris Therapeutics (ACRS) as Buy with a $12 target. UBS's Alex Stansbury rated Kaiser Aluminum (KALU) as Neutral with a $176 target. Wedbush's Laura Chico rated Sionna Therapeutics (SION) as Outperform with a $53 target." datetime: "2026-05-05T16:36:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285240940.md) - [en](https://longbridge.com/en/news/285240940.md) - [zh-HK](https://longbridge.com/zh-HK/news/285240940.md) --- # This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. - Seaport Global analyst Jay Goldberg initiated coverage on **Applied Materials Inc** (NASDAQ:AMAT) with a Buy rating and announced a price target of $500. Applied Materials shares traded at $412.58 on Tuesday. See how other analysts view this stock. - Citizens analyst Jonathan Wolleben initiated coverage on **Biomea Fusion Inc** (NASDAQ:BMEA) with a Market Outperform rating and announced a price target of $9. Biomea Fusion shares traded at $1.49 on Tuesday. See how other analysts view this stock. - Guggenheim analyst Seamus Fernandez initiated coverage on **Aclaris Therapeutics Inc** (NASDAQ:ACRS) with a Buy rating and announced a price target of $12. Aclaris Therapeutics shares traded at $4.68 on Tuesday. See how other analysts view this stock. - UBS analyst Alex Stansbury initiated coverage on **Kaiser Aluminum Corp** (NASDAQ:KALU) with a Neutral rating and announced a price target of $176. Kaiser Aluminum shares traded at $177.15 on Tuesday. See how other analysts view this stock. - Wedbush analyst Laura Chico initiated coverage on **Sionna Therapeutics Inc** (NASDAQ:SION) with an Outperform rating and announced a price target of $53. Sionna Therapeutics shares traded at $40.94 on Tuesday. See how other analysts view this stock. Considering buying AMAT stock? Here’s what analysts think: _Photo via Shutterstock_ ### Related Stocks - [ACRS.US](https://longbridge.com/en/quote/ACRS.US.md) - [KALU.US](https://longbridge.com/en/quote/KALU.US.md) - [SION.US](https://longbridge.com/en/quote/SION.US.md) - [AMAT.US](https://longbridge.com/en/quote/AMAT.US.md) - [BMEA.US](https://longbridge.com/en/quote/BMEA.US.md) - [SSTK.US](https://longbridge.com/en/quote/SSTK.US.md) ## Related News & Research - [Applied Materials Sees Multi-Year AI Boom Driving Record Revenue And Growth Through 2028](https://longbridge.com/en/news/286592782.md) - [JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Applied Materials (NASDAQ:AMAT) Stock](https://longbridge.com/en/news/286590590.md) - [Applied Materials Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/286422553.md) - [Cambridge Investment Research Advisors Inc. Boosts Stake in Applied Materials, Inc. $AMAT](https://longbridge.com/en/news/286734262.md) - [Why Applied Materials (AMAT) Stock Is a Buy Heading Into Its Earnings](https://longbridge.com/en/news/286421049.md)